Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
Blood Advances|August 20, 2020
Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adultsHeather J Symons, Marianna Zahurak, Yilin Cao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2008
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphomaLauri M Burroughs, Paul V O'Donnell, Brenda M Sandmaier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2013
Absence of post-transplantation lymphoproliferative disorder after allogeneic blood or marrow transplantation using post-transplantation cyclophosphamide as graft-versus-host disease prophylaxisJennifer A Kanakry, Yvette L Kasamon, Javier Bolaños-Meade, et al.
The Lancet. Haematology|March 18, 2019
Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trialJavier Bolaños-Meade, Kenneth R Cooke, Christopher J Gamper, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2018
Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not OutcomesShannon R McCurdy, Stephen T Muth, Hua-Ling Tsai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 27, 2016
Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic MalignanciesOrly R Klein, Jessica Buddenbaum, Noah Tucker, et al.
Transplantation and Cellular Therapy|November 7, 2025
Long-Term Follow-Up of the Baltimore Experience with Hematopoietic Cell Transplantation for Severe Aplastic Anemia Using Post-Transplantation CyclophosphamideAmy E DeZern, Marianna Zahurak, Tyler Cavin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 21, 2008
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamideLeo Luznik, Paul V O'Donnell, Heather J Symons, et al.
Pain|June 24, 2025
Over 50 years of research on social disparities in pain and pain treatment: a scoping review of reviewsHanna Grol-Prokopczyk, Rui Huang, Chang Yu, et al.
Blood Advances|June 9, 2026
Donor-Specific Transplant Outcomes from BMTCTN 1702: A Multi-Center Prospective Biological-Assignment TrialAsad Bashey, Brent R Logan, LaQuisa C Hill, et al.
Pageof 22